VEGFR-3 rs307821 polymorphism has been previously evaluated in patients with renal cell carcinoma treated with sunitinib showing a significant correlation with overall survival and disease free survival [38, 39]. This evidence concerns the gene FLT4 and hereditary clear cell renal cell carcinoma.